Tonix Pharma (NASDAQ: TNXP) reported Q3 EPS of ($3.59), in-line with the analyst estimate of ($3.59). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $3.1 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.